Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Michael T. Constantino

Director at Humacyte, Inc. (HUMA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$5K
Total bought / sold$10K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 20SEC HUMAHumacyte, Inc. Buy 11,00043,950 held (+33%) $0.89 $10K -54.5%
  • Buy

    Director Michael T. Constantino bought $10K of HUMA at $0.89 — first open-market purchase in our records; raises the stake by 33%.